Diasorin | DIA - Sales Revenues

Stock Price
63.55
Daily Change
-0.19 -0.30%
Monthly
-9.50%
Yearly
-32.47%
Q1 Forecast
62.02

Diasorin reported EUR280M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Amplifon EUR 652M 88.7M Dec/2025
Avanos Medical USD 180.9M 3.1M Dec/2025
Brookdale Senior Living USD 754.09M 59.07M Dec/2025
Cencora USD 85.93B 32.02M Dec/2025
Diasorin EUR 280M 26M Sep/2025
Encompass Health USD 1.54B 60M Dec/2025
Enovis USD 575.7M 26.8M Dec/2025
GE HealthCare Technologies USD 5.7B 555M Dec/2025
OPKO Health USD 148.45M 3.22M Dec/2025
Pediatrix Medical Group USD 493.77M 896K Dec/2025
Veradigm USD 142.52M 9.38M Dec/2022
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025